Stronger Production Trend and Cost Control Might Change The Case For Investing In DRDGOLD (DRD)

Simply Wall St

Tue, February 17, 2026 at 11:06 AM GMT+9 3 min read

In this article:

DRD

+6.04%

DRDGF

0.00%

GC=F

-1.18%

In August 2025, DRDGOLD Limited reaffirmed production guidance for the year ended 30 June 2026 of 140,000–150,000 ounces of gold, with cash operating costs of about R995,000/kg, and now reports it is trending toward the upper end of that range while keeping unit costs within guidance.

This combination of higher-end production expectations and disciplined cost control, alongside recent earnings and revenue growth with upgraded analyst estimates, has sharpened investor focus on DRDGOLD’s operating performance.

Next, we’ll examine how DRDGOLD’s move toward the top of its production guidance range shapes the company’s broader investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.

What Is DRDGOLD’s Investment Narrative?

To own DRDGOLD, you need to believe in a relatively simple equation: consistent gold recovery from surface resources, disciplined cost control and a management team that has turned that formula into strong returns for shareholders. The latest guidance update, with production trending toward the top of the 140,000–150,000 ounce range while cash costs stay within guidance, supports the near term catalyst that has already been driving interest: solid operational execution aligned with prior communication. Given the already very large one year total return and upgraded analyst estimates, this confirmation matters, but it does not radically change the story; it reinforces it. The bigger swing factors still sit outside the latest update, particularly cost inflation, the pending CFO transition and exposure to South African operating conditions.

However, one key operational risk could quickly change how today’s optimism is viewed. DRDGOLD’s shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.

Exploring Other Perspectives

DRD 1-Year Stock Price Chart

Seven Simply Wall St Community fair value views span from R11.62 to almost R94.69, underlining how differently people see DRDGOLD’s upside. Set that against today’s stronger production guidance and you can immediately see why understanding the operational and cost risks really matters before you decide how to interpret those valuations.

Explore 7 other fair value estimates on DRDGOLD - why the stock might be worth over 2x more than the current price!

Build Your Own DRDGOLD Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

Story continues  

A great starting point for your DRDGOLD research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Our free DRDGOLD research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DRDGOLD's overall financial health at a glance.

Contemplating Other Strategies?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

Find 54 companies with promising cash flow potential yet trading below their fair value.

AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include DRD.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info